These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 18648727

  • 21. Baseline intrinsic heart rate and response to ivabradine treatment in patients with inappropriate sinus tachycardia.
    Kaczmarek K, Klingenheben T, Poddebska I, Urbanek I, Wranicz JK, Cygankiewicz I, Ptaszyński P.
    Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12709. PubMed ID: 31595620
    [Abstract] [Full Text] [Related]

  • 22. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
    Cardiol J; 2015 May; 22(2):227-32. PubMed ID: 25179314
    [Abstract] [Full Text] [Related]

  • 23. [Inadequate, inappropriate sinus-node tachycardia: an old cardiac arrhythmia in a new perspective (II.): Our experiences with the pharmacological treatment].
    Borbola J, Földesi C, Kardos A, Som Z.
    Orv Hetil; 2020 Nov 15; 161(46):1953-1958. PubMed ID: 33190126
    [Abstract] [Full Text] [Related]

  • 24. Effect of diltiazem on exercise capacity after heart transplantation.
    Varnado S, Peled-Potashnik Y, Huntsberry A, Lowes BD, Zolty R, Burdorf A, Lyden ER, Moulton MJ, Um JY, Raichlin E.
    Clin Transplant; 2017 Aug 15; 31(8):. PubMed ID: 28477381
    [Abstract] [Full Text] [Related]

  • 25. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
    Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP.
    J Am Coll Cardiol; 2012 Oct 09; 60(15):1323-9. PubMed ID: 22981555
    [Abstract] [Full Text] [Related]

  • 26. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W, Holland DJ, Rojek A, Wright L, Przewlocka-Kosmala M, Marwick TH.
    J Am Coll Cardiol; 2013 Oct 08; 62(15):1330-8. PubMed ID: 23916925
    [Abstract] [Full Text] [Related]

  • 27. Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
    Adler A, Rosso R, Meir I, Viskin S.
    Europace; 2013 Mar 08; 15(3):362-5. PubMed ID: 23118003
    [Abstract] [Full Text] [Related]

  • 28. Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia: a long-term follow-up study.
    Martino A, Rebecchi M, Sette A, Cicogna F, Politano A, Sgueglia M, de Ruvo E, Volterrani M, Calo' L.
    J Cardiovasc Med (Hagerstown); 2021 Dec 01; 22(11):892-900. PubMed ID: 34747925
    [Abstract] [Full Text] [Related]

  • 29. Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies.
    Mathew ST, Po SS, Thadani U.
    Heart Rhythm; 2018 Feb 01; 15(2):240-247. PubMed ID: 29017929
    [Abstract] [Full Text] [Related]

  • 30. Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients.
    Benezet-Mazuecos J, Rubio JM, Farré J, Quiñones MÁ, Sanchez-Borque P, Macía E.
    Pacing Clin Electrophysiol; 2013 Jul 01; 36(7):830-6. PubMed ID: 23510001
    [Abstract] [Full Text] [Related]

  • 31. Inappropriate sinus tachycardia: focus on ivabradine.
    Abed HS, Fulcher JR, Kilborn MJ, Keech AC.
    Intern Med J; 2016 Aug 01; 46(8):875-83. PubMed ID: 27059112
    [Abstract] [Full Text] [Related]

  • 32. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E, Montaudon M, Chasseriaud W, Gilbert S, Cochet H, Pucheu Y, Horovitz A, Bonnet J, Douard H, Coste P.
    Arch Cardiovasc Dis; 2014 Jan 01; 107(1):33-41. PubMed ID: 24440004
    [Abstract] [Full Text] [Related]

  • 33. Management of inappropriate sinus tachycardia with ivabradine in a renal transplant recipient.
    Kumar Goyal V, Godara S, Chandra Sadasukhi T, Lal Gupta H.
    Drug Discov Ther; 2014 Jun 01; 8(3):132-3. PubMed ID: 25031045
    [Abstract] [Full Text] [Related]

  • 34. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U, Stöckl G, Werdan K.
    Vasc Health Risk Manag; 2016 Jun 01; 12():453-470. PubMed ID: 27895488
    [Abstract] [Full Text] [Related]

  • 35. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K.
    Clin Res Cardiol; 2011 Oct 01; 100(10):915-23. PubMed ID: 21638157
    [Abstract] [Full Text] [Related]

  • 36. Ivabradine as a treatment option for inappropriate sinus tachycardia.
    Retegui G, Quintero M, Ruiz-Borrell M, Revello A.
    Rev Esp Cardiol; 2009 May 01; 62(5):577-9. PubMed ID: 19406075
    [No Abstract] [Full Text] [Related]

  • 37. [A heart without overspeed trip unit].
    Gähwiler R, Templin C, Lüscher TF, Ghadri JR.
    Praxis (Bern 1994); 2014 Apr 23; 103(9):527-31. PubMed ID: 24755501
    [Abstract] [Full Text] [Related]

  • 38. Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation.
    Henmi H, Imamura T.
    Intern Med; 2023 Mar 01; 62(5):813. PubMed ID: 35871598
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of inappropriate sinus tachycardia with ivabradine.
    Annamaria M, Lupo PP, Foresti S, De Ambroggi G, de Ruvo E, Sciarra L, Cappato R, Calo L.
    J Interv Card Electrophysiol; 2016 Jun 01; 46(1):47-53. PubMed ID: 26467151
    [Abstract] [Full Text] [Related]

  • 40. If channel blocker ivabradine vs. β-blockers for sinus tachycardia in patients with takotsubo syndrome.
    Madias JE.
    Int J Cardiol; 2016 Nov 15; 223():877-878. PubMed ID: 27584563
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.